Wave Life Sciences Statistics
Total Valuation
WVE has a market cap or net worth of $1.45 billion. The enterprise value is $906.08 million.
Important Dates
The next confirmed earnings date is Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
WVE has 192.35 million shares outstanding. The number of shares has increased by 21.45% in one year.
| Current Share Class | 192.35M |
| Shares Outstanding | 192.35M |
| Shares Change (YoY) | +21.45% |
| Shares Change (QoQ) | +11.11% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 71.72% |
| Float | 126.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.99 |
| Forward PS | 36.53 |
| PB Ratio | 2.61 |
| P/TBV Ratio | 2.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.26, with a Debt / Equity ratio of 0.03.
| Current Ratio | 11.26 |
| Quick Ratio | 10.93 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.11% and return on invested capital (ROIC) is -33.68%.
| Return on Equity (ROE) | -53.11% |
| Return on Assets (ROA) | -28.23% |
| Return on Invested Capital (ROIC) | -33.68% |
| Return on Capital Employed (ROCE) | -36.89% |
| Weighted Average Cost of Capital (WACC) | -2.98% |
| Revenue Per Employee | $226,492 |
| Profits Per Employee | -$579,139 |
| Employee Count | 317 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.04% in the last 52 weeks. The beta is -1.32, so WVE's price volatility has been lower than the market average.
| Beta (5Y) | -1.32 |
| 52-Week Price Change | +12.04% |
| 50-Day Moving Average | 10.38 |
| 200-Day Moving Average | 10.22 |
| Relative Strength Index (RSI) | 41.11 |
| Average Volume (20 Days) | 4,058,331 |
Short Selling Information
The latest short interest is 13.35 million, so 6.94% of the outstanding shares have been sold short.
| Short Interest | 13.35M |
| Short Previous Month | 13.21M |
| Short % of Shares Out | 6.94% |
| Short % of Float | 10.51% |
| Short Ratio (days to cover) | 2.06 |
Income Statement
In the last 12 months, WVE had revenue of $71.80 million and -$183.59 million in losses. Loss per share was -$1.03.
| Revenue | 71.80M |
| Gross Profit | -110.98M |
| Operating Income | -196.88M |
| Pretax Income | -183.59M |
| Net Income | -183.59M |
| EBITDA | -193.47M |
| EBIT | -196.88M |
| Loss Per Share | -$1.03 |
Full Income StatementBalance Sheet
The company has $544.59 million in cash and $15.72 million in debt, giving a net cash position of $528.88 million or $2.75 per share.
| Cash & Cash Equivalents | 544.59M |
| Total Debt | 15.72M |
| Net Cash | 528.88M |
| Net Cash Per Share | $2.75 |
| Equity (Book Value) | 511.73M |
| Book Value Per Share | 2.66 |
| Working Capital | 511.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$184.01 million and capital expenditures -$991,000, giving a free cash flow of -$185.00 million.
| Operating Cash Flow | -184.01M |
| Capital Expenditures | -991,000 |
| Depreciation & Amortization | 3.41M |
| Net Borrowing | n/a |
| Free Cash Flow | -185.00M |
| FCF Per Share | -$0.96 |
Full Cash Flow StatementMargins
Gross margin is -154.57%, with operating and profit margins of -274.21% and -255.70%.
| Gross Margin | -154.57% |
| Operating Margin | -274.21% |
| Pretax Margin | -255.70% |
| Profit Margin | -255.70% |
| EBITDA Margin | -269.47% |
| EBIT Margin | -274.21% |
| FCF Margin | n/a |